Qatar Biobank Builds Momentum
Thursday, May 23, 2013
Qatar Biobank recently welcomed its 300th participant through the doors of its centre in Hamad Medical City.
Cell Therapy Catapult to work with GSK on Cell Therapies
Wednesday, May 22, 2013
First partnership with large pharma company for Cell Therapy Catapult.
UK-Norwegian Collaboration Aims to Develop a New Living Skin Equivalent Model
Tuesday, May 21, 2013
New in vitro human living skin equivalent model for testing inflammatory responses.
FDA Agreement on Mesoblast’s Use of Singapore Manufacturing Facility for MPCs Clinical Trial Production
Tuesday, May 21, 2013
New facility will support product delineation strategies, increase geographical reach, and reduce risk of single site reliance.
Program for Breakthrough Biomedical Research to Celebrate 15 Years
Tuesday, May 21, 2013
A program that fosters basic science projects of potentially high impact is celebrating 15 years of discovery at UC San Francisco.
UCSF Scientists Use Human Stem Cells to Generate Immune System in Mice
Friday, May 17, 2013
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
Team Successfully Converts Human Skin Cells into Embryonic Stem Cells
Friday, May 17, 2013
The breakthrough marks the first time human stem cells have been produced via nuclear transfer and follows several unsuccessful attempts by research groups worldwide.
Nobel Prize Rockets Stem Cell Program to New Heights
Thursday, May 16, 2013
Shinya Yamanaka's Feat Brings fresh attention to promise of regeneration medicine.
Mesoblast Receives FDA Clearance for Phase 2 Trial of MPCs in Active RA Patients
Thursday, May 16, 2013
In addition, a second Phase 2 trial of MPCs as a first-line biologic treatment for active RA is planned to commence in Europe in 1H 2013.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 1780 |
|
|
